Use access key #2 to skip to page content.
$26.24 0.64 (2.50%)
9/5/2008 4:00 PM

Vertex Pharmaceuticals, Inc. (VRTX)

CAPS Rating:
****

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

View All Commentary (VRTX)

Recs

0

Avatar EclecticRecluse (72.14) Submitted: 5/08/08 8:26 AM : Underperform Start Price: $25.70 VRTX Score: -10.93

Poor Forward Earnings Estimate

Report this Post Replies: 0 | Reply

Featured Broker Partners